Keystone Heart

OverviewSuggest Edit

Keystone Heart Ltd. is a medical device company developing and manufacturing embolic cerebral protection devices to reduce the risk of stroke, neurocognitive decline and dementia caused by brain emboli associated with cardiovascular procedures.

The Company is focused on protecting the brain from emboli to reduce the risk of brain infarcts during TAVR, surgical valve replacement, atrial fibrillation ablation and other cardiovascular procedures. The novel TriGuard™ product pipeline is designed to help interventional cardiologists, electrophysiologists and cardiac surgeons to preserve brain reserve while performing these procedures.

Headquartered in Israel, with US operations in Tampa, FL, Keystone Heart is dedicated to advancing patient care through innovative technology and clinical research. The Company’s management has extensive experience in the fields of interventional cardiology and medical devices.

TypePrivate
Founded2004
HQCaesarea, IL
Websitekeystoneheart.com

Latest Updates

Employees (est.) (Feb 2020)31(+11%)

Key People/Management at Keystone Heart

Pauliina Margolis

Pauliina Margolis

CMO & Vp

Keystone Heart Office Locations

Keystone Heart has offices in Caesarea and Tampa
Caesarea, IL (HQ)
Khalamish St 15
Tampa, US
3000 Bayport Dr #980
Show all (2)

Keystone Heart Financials and Metrics

Summary Metrics

Founding Date

2004

Keystone Heart total Funding

$14 m

Keystone Heart latest funding size

$14 m

Time since last funding

6 years ago

Keystone Heart investors

Keystone Heart's latest funding round in May 2014 was reported to be $14 m. In total, Keystone Heart has raised $14 m
Show all financial metrics

Keystone Heart Online and Social Media Presence

Embed Graph

Keystone Heart News and Updates

Keystone Heart Ltd. and Vasorum Ltd. enter distribution agreement for Celt ACD® Vascular Closure Device

TAMPA, Fla., July 11, 2019 /PRNewswire/ -- Keystone Heart Ltd. today announced that it has signed a distribution agreement with Ireland-based Vasorum Ltd. for sales and marketing of their Celt ACD® Vascular Closure Device. The Celt ACD®, is an arterial puncture closure device that has...

Venus Medtech Completes Merger with Keystone Heart, Ltd.

HANGZHOU, China and CAESAREA, Israel and TAMPA, Fla., Dec. 26, 2018 /PRNewswire/ -- Venus Medtech (Hangzhou) Inc., the preeminent Chinese transcatheter heart valve company, today announced it has closed its Merger with Keystone Heart Ltd., a privately-held medical device company and...

Venus Medtech Announces Agreement to Acquire Keystone Heart, LTD

HANGZHOU, China and CAESAREA, Israel and TAMPA, Florida, Sept. 25, 2018 /PRNewswire/ -- Venus Medtech (Hangzhou) Inc., the preeminent Chinese transcatheter heart valve company, today announced it has signed an agreement to acquire Keystone Heart Ltd., a privately-held medical device...

Keystone Heart Frequently Asked Questions

  • When was Keystone Heart founded?

    Keystone Heart was founded in 2004.

  • Who are Keystone Heart key executives?

    Keystone Heart's key executives are Pauliina Margolis.

  • How many employees does Keystone Heart have?

    Keystone Heart has 31 employees.

  • Who are Keystone Heart competitors?

    Competitors of Keystone Heart include Smith & Nephew, Liberator Medical Supply and Medequip.

  • Where is Keystone Heart headquarters?

    Keystone Heart headquarters is located at Khalamish St 15, Caesarea.

  • Where are Keystone Heart offices?

    Keystone Heart has offices in Caesarea and Tampa.

  • How many offices does Keystone Heart have?

    Keystone Heart has 2 offices.